Biopreservation Market Forecast 2025–2035 | Trends, Challenges & Opportunities

Market Overview

The global Biopreservation Market is valued at USD 7.11 billion in 2024 and is projected to reach a value of USD 37.76 billion by 2035 at a CAGR (Compound Annual Growth Rate) of 16.40% between 2025 and 2035.

The Biopreservation Market refers to the global industry focused on preserving biological samples, such as cells, tissues, DNA/RNA, and organs, through temperature-controlled environments or chemically treated means. Biopreservation plays a pivotal role in advancing research and development in biotechnology, pharmaceuticals, and regenerative medicine. With the increasing demand for personalized medicine, stem cell therapy, and organ transplantation, the need for efficient and long-term storage solutions is rapidly growing. Major growth drivers include the rise in chronic diseases, escalated research in genomics and biobanking, and increasing government and private investments in healthcare infrastructure. Moreover, technological advancements in cold chain logistics and preservation protocols are enhancing market efficiency and safety, further fueling the growth of this dynamic sector.

Our comprehensive Biopreservation Market report is ready with the latest trends, growth opportunities, and strategic analysis- View Sample Report PDF

Market Segmentation & Market Key Companies

Segment Covered

By Products

• Equipment
•     Freezers
•     Refrigerators
•     Consumables
•     Liquid Nitrogen
• Media
•     Pre-formulated
•     Home-brew
• Laboratory Information Management System (LIMS)

By Application

• Regenerative Medicine
• Regenerative Medicine
•     Cell Therapy
•     Gene Therapy
•     Other Regenerative Medicines
• Bio-banking
•     Human Eggs
•     Human Sperms
•     Veterinary IVF
• Drug Discovery

By Region

• North America (U.S., Canada, Mexico)
• Europe (Germany, France, U.K., Italy, Spain, Nordic Countries, Benelux Union, Rest of Europe)
• Asia Pacific (China, Japan, India, New Zealand, Australia, South Korea, South-East Asia, Rest of Asia Pacific)
• Latin America (Brazil, Argentina, Rest of Latin America)
• Middle East and Africa (Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of MEA)

Companies Covered  

• BioCision LLC (U.S.)
• BioLife Solutions Inc. (U.S.)
• Cesca Therapeutics Inc. (U.S.)
• Core Dynamics Ltd. (U.S.)
• Custom Biogenic Systems Inc. (U.S.)
• Lifeline Scientific Inc. (U.S.)
• Merck KGaA (Germany)
• Princeton CryoTech Inc. (U.S.)
• VWR International (U.S.)
• Azenta US Inc. (U.S.)
• Thermo Fisher Scientific Inc. (U.S.)
• MVE Biological Solutions (U.S.)

Market Dynamics

The dynamics of the biopreservation market are rooted in the rising reliance on high-quality biomaterials for clinical and research use. As scientific innovation accelerates in fields such as pharmaceuticals, regenerative medicine, and cell therapy, there is a growing requirement for preserving biospecimens under tightly controlled conditions. This market is being propelled by factors such as the increasing use of biopreservation in stem cell therapy, the burgeoning growth of biobanks globally, and a significant increase in global collaborations between academic institutions, biotech firms, and hospitals. In addition, the prevalence of lifestyle-related diseases has boosted the demand for advanced therapeutics, which in turn, depends heavily on the accurate and long-term storage of biological samples.

However, the market isn't without its restraints. The high cost of automated systems and equipment, concerns around contamination and regulatory compliance, and the need for consistent temperature monitoring can create roadblocks for smaller or developing facilities. Furthermore, ethical concerns and data safety regarding biobanking may limit some aspects of biopreservation implementation. Nevertheless, technological interventions such as AI-integrated monitoring systems, cloud-based data management, and innovations in cryopreservation techniques are bridging the gap between challenges and their resolutions, ensuring stable and lucrative growth.

Top Trends in the Market

Several dominant trends are shaping the future trajectory of the global biopreservation market. One of the most transformative trends is the integration of artificial intelligence (AI) and IoT-enabled monitoring systems with container storage solutions. These technologies enhance sample tracking, ensure stable temperature conditions, and prevent spoilage due to human error. Another key trend is the rise of personalized medicine, which requires precision-based storage solutions aligned with individual genetic profiles. This has sparked a higher demand for biobanked samples and is fueling the role of biopreservation in genetics and rare disease diagnosis.

Additionally, the increasing relevance of stem cell research and regenerative medicine continues to act as a catalyst for biopreservation, with leading pharmaceutical companies investing heavily in cryopreservation and tissue preservation methods. A notable trend is the expansion of cord blood banking, aiding prenatal diagnostics and neonatal treatments through stem cell use. The market is also benefiting from biotechnology firms collaborating with renowned research institutions to push the boundaries of clinical research and therapeutic development. With a focus on green and sustainable preservation techniques—such as the use of less toxic cryoprotectants and eco-friendly preservation storage systems—market players are not only improving biological outcomes but also aligning with environmental goals.

Recent Market Developments

• In June 2023, BioLife Solutions, Inc. unveiled a novel controlled-rate freezer (CRF) with a substantial capacity to enhance and diversify its CRF product range. This recent addition to their lineup is strategically designed to cater to the requirements of both autologous and allogeneic cell and gene therapy (CGT) clients and to bolster the company's capabilities in commercial-scale manufacturing.
• In January 2023, Thermo Fisher Scientific Inc. finalized its merger and acquisition (M&A) arrangement with The Binding Site Group, a renowned global leader in specialty diagnostics. This strategic maneuver was undertaken to augment Thermo Fisher's existing portfolio within specialty diagnostics.
• In June 2023, PHC Holdings Corporation officially stated that it purchased the final 30% of SciMed (Asia) Pte. Ltd. This strategic move has resulted in SciMed becoming a wholly owned subsidiary of PHCHD. This acquisition is pivotal in the company's endeavor to extend its influence within the life sciences sector throughout the Asia-Pacific region.

Top Report Findings

• The swift advancement of cell and gene therapies has heightened the call for Biopreservation technologies. As an illustration, Ori Biotech introduced a cell and gene therapy platform in January 2022, after acquiring more than USD 100 million through Series B funding.
• The North American region generated more than 46.2% of revenue share in 2024.
• The Asia Pacific region is expected to grow quickly from 2025 to 2035.
• The Equipment segment accounted for the most significant market growth and contributed over 71.6% of the total revenue share in 2024.
• The Bio-Banking segment revealed the most important market growth, contributing more than 68.4% of the total revenue share in 2024.

Challenges in the Market

Despite its upward trajectory, the biopreservation market faces a wide range of challenges that must be addressed to ensure scalable and sustainable growth. One of the primary hurdles is the high setup and operational costs associated with advanced preservation equipment, including cryogenic storage units and controlled-rate freezers. These expenses often restrict access for smaller research institutions or startups. Another prominent issue is the risk of degradation or contamination of samples due to deviations in storage conditions or power failures, necessitating stringent monitoring and maintenance.

Further complicating the landscape are regulatory compliance issues, especially in countries where biobanking laws are either non-existent or in their infancy. Uncertainty regarding data ownership, ethical concerns over consent in storing human tissues, and privacy of genetic data pose severe concerns. Additionally, variations in global standards for biopreservation across different countries can make international collaboration and sample exchange difficult. Addressing these core challenges is crucial to maintaining the integrity of biological samples and achieving scientific breakthroughs.

Opportunities in the Market

While the biopreservation sector encounters several challenges, it is also ripe with opportunities that could redefine healthcare and research in the next decade. One major area of potential lies in the global expansion of biobanks, especially in emerging economies where healthcare research is gaining traction. The introduction and scaling of biopreservation in regions like Asia-Pacific, Latin America, and Africa offer lucrative growth avenues for market players seeking untapped markets.

Another considerable opportunity is the increasing adoption of regenerative and personalized medicine, which requires robust sample preservation systems. Breakthroughs in organ transplantation and tissue engineering further enhance the demand for strong biosample repositories. Moreover, emerging technologies such as nanotechnology-based cryoprotectants and automated storage and retrieval systems are opening new frontiers for streamlined sample handling and longer preservation periods. Lastly, the greater integration of blockchain and cloud platforms for biobank data management and traceability presents a promising step toward overcoming regulatory and data security concerns, enabling the market to achieve global scalability.

Key Questions Answered in the Market Report

1. What are the major drivers influencing the growth of the biopreservation market?
2. What are the key sectors contributing to increasing demand for biopreservation globally?
3. How are innovations in cryopreservation and genome storage technologies shaping market trends?
4. Which companies are leading in the development and implementation of biopreservation systems?
5. What are the most significant challenges faced by market players in the biopreservation industry?
6. How is AI and smart monitoring revolutionizing storage techniques and biospecimen integrity?
7. What regions are expected to experience the fastest market growth in the coming years?
8. How does regulatory compliance impact the storage and use of biopreserved materials across borders?

Regional Analysis – North America

North America continues to be the dominant player in the global biopreservation market, accounting for a significant share of revenue and technological innovation. This regional leadership can be attributed to its well-established healthcare infrastructure, robust funding from both private sectors and government agencies, and the presence of leading biotechnology and pharmaceutical companies. The United States, in particular, offers a strong base of academic and clinical research institutions that actively use biopreservation for genome research, therapeutic development, and regenerative medicine.

Biobanks across the U.S. and Canada have witnessed considerable expansion due to increased investment in personalized medicine initiatives. The rapidly growing clinical adoption of stem cell therapies for treating various chronic and degenerative diseases further fuels market demand. Moreover, North America has made considerable strides in integrating AI systems for temperature monitoring and automating biosample storage and retrieval processes. Leading players in biopreservation technology, such as Thermo Fisher Scientific, BioLife Solutions, and AMSBIO, are headquartered in the region, helping North America maintain its competitive edge.

Well-regulated bioethical standards and strong data security laws have also made North America an attractive hub for international collaborations. Coupled with technological prowess and high healthcare spending, the region presents existing and new market entrants with substantial growth opportunities, especially in next-gen applications like organ regeneration and advanced gene therapy trials.

Heightened Market Interest: Our Complete Report Delivers Extensive Analysis and Trends!

Conclusion

The biopreservation market stands at the intersection of scientific breakthroughs and technological evolution, playing a critical role in shaping the future of healthcare and research. Rapid advancements in biotechnology, increased global health challenges, and expanding applications in precision medicine are all paving the road for sustained market growth. While challenges such as high costs and regulatory hurdles persist, innovations in automation, AI, and environmentally conscious preservation techniques are reshaping the landscape. As biopreservation becomes more integral to medical discovery and therapeutic intervention, particularly in North America, the market’s future looks highly promising and poised for expansion.